Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals Financial Statements


Terns Pharmaceuticals Financial Overview

Terns Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.127; its P/E ratio is -2.77; Terns Pharmaceuticals is scheduled to report earnings on May 16, 2022, and the estimated EPS forecast is $-0.64. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 1.00M$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -14.08M$ -13.82M$ -13.88M$ -11.87M$ -10.82M
EBITDA$ -13.81M$ -13.55M$ -13.76M$ -11.76M$ -10.70M
Net Income Common Stockholders$ -13.93M$ -13.77M$ -14.25M$ -11.84M$ -10.74M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 13.76M$ 74.85M$ 139.81M$ 151.27M$ 165.98M
Total Assets$ 144.86M$ 156.67M$ 168.07M$ 179.89M$ 188.01M
Total Debt$ 1.44M$ 1.59M$ 12.88M$ 19.34M$ 0.00
Net Debt$ -12.32M$ -73.27M$ -126.93M$ -131.93M$ -165.98M
Total Liabilities$ 7.64M$ 7.95M$ 7.77M$ 7.73M$ 6.67M
Stockholders Equity$ 68.59M$ 137.22M$ 148.72M$ 160.30M$ 172.16M
Cash Flow
Free Cash Flow$ -11.17M$ -13.54M$ -10.87M$ -8.16M$ -8.80M
Operating Cash Flow$ -11.16M$ -13.30M$ -10.67M$ -8.08M$ -8.76M
Investing Cash Flow$ -15.97M$ 9.49M$ -6.42M$ 4.44M$ -20.90M
Financing Cash Flow$ 124.00K$ 0.00$ 16.00K$ 797.00K$ -1.59M
Currency in USD

Terns Pharmaceuticals Earnings and Revenue History

Terns Pharmaceuticals Debt to Assets

Terns Pharmaceuticals Cash Flow

Terns Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis